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Abstract: Cancer represents a serious global health problem, and its incidence and mortality are
rapidly growing worldwide. One of the main causes of the failure of an anticancer treatment is the
development of drug resistance by cancer cells. Therefore, it is necessary to develop new drugs
characterized by better pharmacological and toxicological profiles. Natural compounds can represent
an optimal collection of bioactive molecules. Many natural compounds have been proven to possess
anticancer effects in different types of tumors, but often the molecular mechanisms associated with
their cytotoxicity are not completely understood. The endoplasmic reticulum (ER) is an organelle
involved in multiple cellular processes. Alteration of ER homeostasis and its appropriate functioning
originates a cascade of signaling events known as ER stress response or unfolded protein response
(UPR). The UPR pathways involve three different sensors (protein kinase RNA(PKR)-like ER kinase
(PERK), inositol requiring enzyme1α (IRE1) and activating transcription factor 6 (ATF6)) residing on
the ER membranes. Although the main purpose of UPR is to restore this organelle’s homeostasis,
a persistent UPR can trigger cell death pathways such as apoptosis. There is a growing body of
evidence showing that ER stress may play a role in the cytotoxicity of many natural compounds. In
this review we present an overview of different plant-derived natural compounds, such as curcumin,
resveratrol, green tea polyphenols, tocotrienols, and garcinia derivates, that exert their anticancer
activity via ER stress modulation in different human cancers.
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1. Introduction
Endoplasmic reticulum (ER)is the organelle in eukaryotic cells, described for the first time by
Porter et al. in 1945 [1] after analyzing chicken fibroblasts by using electron microscopy. It appears
as a membrane network including elongated tubules and flattened discs that span a great area of
the cytoplasm. ER consists of the smooth and the rough ER that can exist either as interconnected
or spatially separated compartments [2]. It is physically in contact with mitochondria in specific
regions called mitochondria-associated membranes (MAMs) that play a very important role in Ca2+
homeostasis [3].
The ER performs many essential functions including folding and post-translational processing
of membrane-bound and secreted proteins, lipid synthesis, degradation of glycogen, detoxification,
and Ca2+ storage and release [4]. The proper ER luminal calcium concentration is also essential for
its protein folding and posttranslational modification actions since molecules such as chaperonins,
protein disulfide isomerases (PDIs), N-glycosylating proteins, and other enzymes need the correct
oxidoreductase potential to work appropriately [5].
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Various stress factors, such as hypoxia, starvation, oxidative insults, changes in pH, Ca2+ depletion,
hypoglycemia, ATP depletion, and viral infections, can disturb ER homeostasis. All these aspects can
interfere with correct protein folding, finally leading to the accumulation of misfolded or unfolded
proteins, generating a condition known as ER stress [6]. In response to such a stress state, cells
have evolved an evolutionary conserved signal transduction pathway called UPR (unfolded protein
response) whose principal aim is to restore ER homeostasis [7]. Three different ER transmembrane
sensors, inositol requiring enzyme1α (IRE1α), protein kinase RNA(PKR)-like ER kinase (PERK), and
activating transcription factor 6 (ATF6) detect the unfolded or misfolded proteins accumulated in the
ER and initiate three distinct UPR branches, respectively, to overcome stress and restore homeostasis.
However, when the stress conditions are too intense and cannot be turned back, the UPR activates a cell
death pathway, generally via intrinsic apoptosis involving the mitochondria [6]. For this reason, under
toxic and unresolved stress conditions, UPR transforms the cell destiny from survival to death [8].
However, novel ER stress-independent functions of UPR are here described; in macrophages X-box
binding protein1 (XBP1) mediates the secretion of pro-inflammatory cytokines by the Toll-like receptor,
independently of ER stress activation [9]. XBP1 is important for secretory cells and for the formation of
plasma cells. In B cells that differentiate to plasma cells, XBP1 activation is differentiation-dependent
and not a UPR-dependent event [10].
Cancer represents one of the leading causes of death worldwide. The analysis presented in the
GLOBOCAN report estimated 18.1 million new cases of cancers and 9.6 million cancer deaths in the
world in 2018 [11].
Over the past several decades, the discovery of plant-based drugs contributed to develop
anticancer drugs, some of which have been historically approved in United States by the Food
and Drug Administration (FDA) such as paclitaxel, camptothecin, vincristine, and their analogs [12].
Natural compounds represent a heterogeneous ensemble of structures that can be exploited to develop
future effective drugs. Natural compounds could be originated from plants, animals, and produced
from microbes, and many of them have shown a low risk of side effects in clinical trials [13]. Natural
compounds can be utilized in different manners in cancer management: as chemopreventive [14],
as chemotherapeutic [15], or chemosensitizer agents [16]. For this reason, the research for new bioactive
molecules present in natural compounds with antitumor capacity is highly encouraged.
In this review, we will examine some classes of natural compounds showing the ability to induce
ER stress-related death in cancer cells. In particular, we will focus on preclinical studies (in vitro
and in vivo approaches) by reporting the ER stress-related anticancer activity exerted by natural
compounds, such as curcumin, resveratrol, green tea polyphenols, quercetin, garcinia, tocotrienols,
and new recent other compounds, in different types of human cancers.
2. Endoplasmic Reticulum Stress Response Pathways
2.1. UPR
The UPR represents a cellular stress response starting in the ER, controlled by three distinct
sensors, IRE1α, PERK, and ATF6. Normally the ER resident chaperone, known as glucose-regulated
protein 78 (GRP78) or binding immunoglobulin protein (BiP) is bound to the ER luminal domain
of the three sensors, maintaining them in an inactive state [17]. Once detached from BiP, IRE1 and
PERK form homodimers or oligomers, and through autophosphorylation, activate their downstream
pathways [17].
Upon release by BiP, the active form of ATF6 moves to the nucleus and promotes the transcription
of different ER chaperones [8].
2.2. IRE1 Pathway
The IRE1 pathway is the most evolutionarily conserved arm of the UPR, activated in different
processes, both physiological and pathological such as those inducing ERAD (ER-associated
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degradation) [18], lipid synthesis [19], and protein secretion [20]. IRE1 is a type I protein receptor
with an N-terminal ER luminal sensing domain and a cytosolic C-terminus domain enclosing both an
endoribonuclease domain and a Ser/Thr kinase domain. In humans, there are two IRE isoforms, IRE1α
and IRE1β; the first one is expressed ubiquitously on the ER membranes, while the second one is found
only on the epithelial cells of the gastrointestinal tract [8]. Upon ER stress condition, IRE1α dissociates
from BiP, dimerizes, and autophosphorylates, converting to its active form. Once active, IRE1α triggers
its endonuclease activity responsible for X-box binding protein1 (XBP1) mRNA splicing. XBP1s
(XBP1 spliced) mRNA encodes for a stable transcription factor targeting a range of genes involved in
pro-survival responses [21]. However, IRE1α, in its active state, can activate another downstream signal
through post-transcriptional modification of different substrates via regulated IRE1-dependent decay
(RIDD) whose activation tends to trigger apoptosis. Hence, IRE1α via oligomerization induces XBP1
mRNA splicing, whereas dimerization induces RIDD. Active IRE1α also interacts with tumor necrosis
factor receptor-associated factor 2 (TRAF2) leading to the increment of apoptosis signal-regulating
kinase 1 (ASK1) and JUN N-terminal kinase (JNK), and in turn, induces apoptosis [22].
2.3. PERK Pathway
PERK is an ER transmembrane protein associated with BiP in its inactive form, but upon
dissociation from BiP in response to UPR triggering, it is activated by oligomerization and
autophosphorylation [8]. Active PERK attenuates mRNA translation and prevents the arrival of new
proteins into the ER compartment. This action is mediated by phosphorylation-mediated inactivation
of the eukaryotic translation initiation factor 2 (eIF2α). The phosphorylation of eIF2α blocks the
recycling of eIF2α in its active GTP-bound state, needed for starting polypeptide chain synthesis,
leading to the attenuation of general protein translation. This process is crucial for decreasing the
ER protein burden and to resolve ER stress [23]. This block in protein translation is not absolute;
indeed, in the meantime, eIF2α phosphorylation paradoxically regulates the expression of activating
transcription factor 4 (ATF4), a member of the CCAAT/enhancer binding protein family (C/EBP)
family of transcription factors [24]. ATF4, in turn, regulates the expression of genes involved in the
restoration of normal cellular homeostasis. Among its target genes, there is the pro-apoptotic C/EBP
homologous protein (CHOP) [25]. CHOP and ATF4 upregulate the transcription of growth arrest and
DNA-damage-inducible protein 34 (GADD34), which in turn causes the dephosphorylation of eIF2α.
If ER stress is irreversible, ATF4-CHOP activation can induce the apoptotic pathway [26].
2.4. ATF6 Pathway
ATF6 is an ER transmembrane protein and a member of the leucine zipper family of transcription
factors [27]. Two ATF6 homologues are expressed in mammalian cells: ATF6α and ATF6β. Following
UPR activation, ATF6α moves to the Golgi apparatus where it is processed by site-1 and site-2
proteases (S1P and S2P) and is transformed in a cytosolic fragment: cleaved ATF6α. In this active
form, it translocates to the nucleus and acts as a transcription factor regulating the expression of
genes presenting ATF/cAMP response elements or ER stress response elements (ERSE) within their
promoter, such as BiP, and protein disulfide isomerase (PDI). Unlike ATF6α, ATF6β is not crucial in
responses to UPR or regulation of ER chaperones. ATF6β has been shown to inhibit ATF6α-mediated
activity during UPR [28]. A study also shows that ATF6α regulates the transcription of ERAD
components. Levels of ERAD components, including ER degradation-enhancing α-mannosidase-like
protein (EDEM), hydroxymethyl glutaryl-coenzyme A reductase degradation protein 1 (HRD1), and
Herp, were found to be lower in ER stress-induced ATF6α−/− mouse embryonic fibroblasts (MEFs)
compared to ATF6α+/+ MEFs. While ATF6 activity is mainly pro-survival, during severe and sustained
ER stress, it can increase CHOP expression that is associated with cell death [29].
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3. ER Stress Mediates UPR for Anticancer Strategies
ER stress is primarily a pro-survival adaptive response against different types of cellular insults.
However, in the presence of severe, prolonged, and sustained ER stress conditions, ER
stress-mediated UPR might fail to re-establish ER homeostasis and switches from pro-survival to
pro-death mechanisms [6]. Although the molecular mechanisms related to this switching are not
completely understood, it has been described that UPR utilizes some of the sensors and executioners
of pro-survival components to activate a pro-death pathway in response to severe ER stress [8]. Cancer
cells adapt UPR to alleviate the ER stress condition as a survival approach for progression [30]. UPR in
cancer has also been described to participate in mechanisms involved in resistance to chemotherapy or
radiation [31]. Some studies demonstrated that prolonged and severe ER stress can induce apoptosis,
offering an interesting therapeutic rationale for suppression of cancer through the accumulation of
unfolded proteins [8].
3.1. Pro-Apoptotic Signals Involving IRE1α-XBP1
The IRE1 sensor is usually associated with pro-survival effects during ER stress conditions through
the induction of different chaperones [32]. During severe and sustained ER stress, it has been shown
that IRE1α can activate a pro-apoptotic signaling. Activation of JNK represents one of the better-known
mechanisms observed in the pro-death activity of IRE1α. This ER stress sensor activates JNK and
IRE1α knockout to reduce JNK activity, suggesting that IRE1α represents an upstream activator of the
JNK pathway. TRAF2 can mediate the JNK activation by IRE1α [33]. In turn, JNK induces apoptosis
by increasing reactive oxigene species (ROS) production, by enhancing the expression of pro-apoptotic
BH3 only members and, in the opposite way, by reducing the expression of anti-apoptotic Bcl-2
family members. The pro-apoptotic proteins Bcl-2-associated X protein (Bax) and Bcl-2 homologous
antagonist/killer (Bak) form complexes with cytosolic region of IRE1α in response to ER stress inducers
and are essential for IRE1α signaling [34]. IRE1α, as previously discussed, could regulate XBP1 mRNA
splicing to produce mature XBP1. Different studies indicated that the IRE1α-XBP1 signaling was
observed in different human cancers including breast and hepatocellular cancer [35]. In breast cancer
cells, XBP1’s active form increases the tolerance of cells to hypoxia [20].
Under sustained ER stress, IRE1α stimulates activation of RIDD to promote apoptosis. The
molecular mechanisms of RIDD-regulated apoptosis are still unclear but recently it has been proposed
that RIDD inactivates anticaspase-2 pre-miRNAs, whose cleavage leads to the generation of active
caspase-2, which has a pro-apoptotic role [18].
3.2. Pro-Apoptotic Signals Involving PERK-eIF2a-ATF4/CHOP
Upon severe stress conditions, active PERK phosphorylates eIF2α, which in turn activates
ATF4. The transcription factor ATF4 binds the promoter region of the CHOP gene, increasing
its mRNA expression and subsequently its protein levels [21]. CHOP represents a crucial player
in ER stress-mediated cell death and all three branches of UPR can affect CHOP expression [36].
During persisting ER stress, ATF4 and CHOP promote cell death by activating genes involved
in protein synthesis, such as GADD34 and ERO1α (endoplasmic reticulum oxireductin1α) [37];
GADD34, whose upregulation represents a pro-apoptotic mechanism depending on CHOP expression,
induces the dephosphorylation of eIF2α and thus restores protein synthesis, whereas ERO1α, which is
involved in the oxidation of PDI, leads to a condition of hyper-oxidation in ER [30]. By augmenting
ERO1α expression, CHOP also promotes Ca2+ release via channel inositol 1,4,5-triphosphate
receptor (IP3R) from ER to the cytoplasm. The increase of Ca2+ in the cytoplasm activates the
calcium/calmodulin-dependent protein kinase II (CaMKII), which acts as an upstream molecule
regulating apoptosis [38].
CHOP can definitely activate a death program inducing both extrinsic and intrinsic apoptotic
pathways. CHOP up-regulates death receptor 5 (DR5) together with caspase-8 activation, which
Int. J. Mol. Sci. 2019, 20, 961 5 of 24
in turn generates the truncated form of Bid (tBid) and transports it into the mitochondria [39]. On
the other hand, CHOP can also trigger the intrinsic apoptotic pathway, decreasing the expression of
anti–apoptotic Bcl-2 and Bcl-xL proteins, while increasing the expression of pro-apoptotic proteins
such as Bak, Bax, Bim, Puma, and Noxa [40]. Besides the interplay between ER and mitochondrial
intrinsic apoptosis pathway, activation of ER-resident caspase, during ER stress, represents another
mechanism to induce apoptosis. Indeed, under ER stress, the active form of rodent caspase-12 and
human caspase-4 activates caspase-9, which in turn activates caspase-3, triggering apoptosis [41].
3.3. Pro-Apoptotic Signals Involving ER Ca2+ Release
The perturbation of Ca2+ levels represents another method regulating the intrinsic apoptosis
pathway involving ER. ER-associated caspase-8 cleaves BAP31, an integral ER membrane protein
forming the p20 fragment, thus abolishing its pro-survival function [42]. Moreover, the p20 fragment
exerts pro-apoptotic signals by releasing Ca2+ from ER into the cytosol. Once in the cytosol, Ca2+ is
subsequently internalized by the mitochondria, resulting in mitochondrial fission and cytochrome
c release. Edelfosine, an antitumor agent, induces the cleavage of BAP31 with the formation of
pro-apoptotic p20 fragment and causes a gradual Ca2+ release from ER in HeLa cells [43].
3.4. The Role of UPR in Cancer Cells
Numerous studies reported that UPR is often upregulated in cancer, suggesting its supportive
role to tumor progression [31]. Indeed, ER stress and UPR are involved in all different stages of tumor
progression. In the early stages of transformation, the high demand for proteins to sustain growth
induces ER stress that in turn activates a pro-survival UPR, increasing the protein folding capacity.
For example, the inhibition of IRE1α RNAse activity decreases breast cancer cell growth in vitro [44].
During tumor progression, extrinsic stress factors for tumors, such as hypoxia, nutrient starvation, and
high cell density, induce ER stress, and the resulting adaptative UPR can promote the expression of
pro-angiogenic factors to resolve hypoxia and can rewire the metabolic pathways to increase nutrient
supply. IRE-XBP1’s signaling can sustain cancer growth in hypoxic condition, likely through interaction
with HIF1α [45]. In the metastatic stage, the epithelial to mesenchimal transition (EMT) allows for the
loss of cell to cell contacts, favoring the formation of a migratory and invasive phenotype. Activation
of ER stress has been described to help cancer cells in EMT by overcoming the stress of cell detachment
and this involves both the IRE-XBP1s and PERK-eIF2α-ATF4 signaling pathways [46,47]. Finally,
during chemotherapy, UPR is an important mechanism that can induce chemoresistance in cancer by
enhancing drug efflux from the cell. It has been reported that knockdown of BiP, ATF6, ATF4, and
XBP1s can resensitize cancer cells to chemotherapy [48,49]. Constitutive activation of cytoprotective
UPR signaling supports cancer cell progression and chemoresistance. However, upon prolonged or
severe ER stress condition, a persistent UPR can induce a pro-death program. Therefore, to obtain an
antitumor activity through the ER stress modulation, two approaches can be followed: on the one
hand, the adaptative UPR can be inhibited for rendering the cells intolerant to ER stress and on the
other hand, a sustained ER stress, activating pro-death signaling, can be induced.
4. Natural Compounds
For millennia, plants represented fundamental components of human life. We use plants not only
as a source for food, beverages, cosmetics, and dyes, but also as drugs in medicine. A healthy diet
including the daily consumption of fruits, vegetables, and spices can be an effective way to prevent the
development of cancer, on the basis of the bioactive compounds contained in these foods [50]. These
molecules are also known as phytochemicals, or nutraceuticals, and can represent plant secondary
metabolites. The use of natural products constitutes a promising intervention to prevent, inhibit,
or reverse the process of carcinogenesis [51]. Natural compounds are characterized by antioxidant,
anticarcinogenic, antimutagenic, and detoxification properties [52] that could be used to produce new
drugs with effective anticancer activity.
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Although many antitumor compounds have been demonstrated, unfavorable side effects and
drug resistance still represent limitations of current anticancer therapy [53]. Indeed, the side effects of
traditional drugs prevent clinical outcomes. Thus, researchers need to identify new agents to develop
more reliable therapies. Once the curative potential of plant-derived drugs is known, it is possible to
investigate the synergistic or additive effects that result from the assortment of compounds occurring
in plants [54]. In addition, the toxicity of natural compounds is usually less compared to traditional
drugs. Thus, their use is supposed to expand the efficacy of traditional anticancer agents, and at the
same time, to decrease their toxicity. Natural compounds and traditional agents, combined together,
would potentially lower the dose of the classic drugs that is needed to obtain the therapeutic outcome,
consequently limiting their detrimental effects [55]. To reach a successful anticancer treatment strategy,
it is important to better clarify how the natural compounds interact with cellular targets. Hence, affecting
the increase of ER stress related protein response could represent an interesting approach to modify the
homeostasis of the ER in cancer cells in order to activate apoptosis. Although ER stress can promote
the survival of cancer cells, under specific conditions, it can support cell death. Different natural
compounds have been reported to induce ER stress-related apoptosis in malignant cells [30,56,57].
In this review article, we discuss the ER stress-involving antitumor mechanisms of the most known
natural compounds, and of some new natural compounds, in the most common human cancers (Figure 1).
4.1. Role of ER Stress in Curcumin-Induced Apoptosis in Cancer
Curcumin is a polyphenol compound extracted from the turmeric rhizome of Curcuma Longa
plant, and is a yellow spice widely used in Indian cooking, textile dyes, and in traditional Ayurvedic
medicine [57]. Over the past ten years, in vitro experiments have demonstrated the anticancer effects
of curcumin in different cancer cell lines by inducing cell cycle arrest and apoptosis, most importantly
through modulation of several distinct cancer targets [14]. Garrido-Armas et al. recently demonstrated,
in A172 human glioblastoma cell line, that curcumin can cause cell death via a paraptosis pathway
involving the ER. The authors observed changes in the expression of IRE1α and ATF6 genes, miR27a,
miR-222, and miR-449 after exposure of the cells to curcumin [58].
As discussed in different papers, curcumin can induce cancer cell death and the molecular
mechanisms of curcumin-induced apoptosis in metastatic prostate cancer cells were recently
investigated by Rivera et al. These authors, utilizing a gel-free shotgun quantitative proteomic analysis
associated with tandem mass tag isobaric labeling-based-signaling networks, revealed that curcumin
promoted ER stress-mediated apoptosis in PC3 prostate cancer cells. The mechanisms by which this
compound caused cell death were associated with ROS production, autophagy, and UPR induction,
in particular with increased BiP, IRE1α, PDI, and calreticulin expression [59]. Curcumin was also able
to induce apoptosis in the WEHI-3 murine myelomonocyte leukemia cell line in a dose-dependent
manner. Interestingly, curcumin increased CHOP, ATF6, IRE1, and caspase-12 expression levels.
Therefore, curcumin increased ROS production and Ca2+ release in the cytosol but decreased the level of
mitochondrial membrane potential [60]. Roberts et al., investigating the effects of combined treatment
with curcumin and sildenafil in different gastrointestinal tumor cell lines, demonstrated, using siRNA
experiments, that PERK and ATF6 are involved in curcumin combined with sildenafil cytotoxicity [61].
In LoVo and HT-29 human colorectal cancer cell lines, curcumin improves the anticancer activity of
irinocan by increasing ROS production and by activating the ER stress pathway [62]. The rhizome
of many Curcuma species is rich in other phenolic compounds, collectively called curcuminoids,
consisting of a mixture of curcumin, demethoxycurcumin (DMC), and bisdemethoxycurcumin (BDMC).
In the NCI H460 human lung cancer cell line, BDMC significantly induced apoptotic death as indicated
by activation of caspase-3, -8, and -9, and increased ROS levels and Ca2+ production, together with
increased ER stress associated proteins such as BiP, CHOP, IRE1(-α and -β), ATF6 (-α and -β), and
caspase-4 [63]. In the same human lung cancer cell line, DMC was also able to promote apoptosis by
activating caspase-3, -8, and -9, and to promote apoptosis-inducing factor (AIF), Endo G and poly
(ADP-ribose) polymerase (PARP) expression. Furthermore, its anticancer activity occurs also through
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GRP78, GADD153, IRE1β, ATF6 (-α and -β), and caspase-4 increased expression [64]. In SW620 colon
cancer cells, B63, a mono-carbonyl analogue of curcumin synthetized to increase its biological activity
and bioavailability, showed significant anti-proliferative and pro-apoptotic effects by up-regulating the
levels of Bad and Bim proteins and enhancing cytochrome c release from mitochondria. Moreover, its
anticancer activity was dependent on ER stress activation [65]. In two different human ovarian cancer
cell lines (A2780 and CP70), the curcumin analogue B19 induced apoptosis that was more effective
than curcumin in the activation of caspase-3. At an apoptosis-promoting concentration, B19 induced
ROS production and ER stress activation; similar to curcumin, B19 acts through different molecular
pathways, including ROS and ER stress [66].
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Figure 1. ER str ss-relat d apoptosis trigger d b atural compounds. If the adaptive UPR pathway
is not able to restore the ER function, upon severe or prolonged ER stress, activation of ER stress
sensors can lead to apoptosis. A lot of natural compounds can induce ER stress, which leads to
activation of the thre ER senso s. Dissociation of BiP from all three ensors PERK, IRE1, and ATF6
leads to generation of their active forms. Active PERK dimerizes, autophosphorylates, and via the
eIF2α/ATF4/CHOP pathway, modulates intrinsic and extrinsic apoptosis pathways. Active IRE1
has been demonstrated to i duce th expression of Bcl-2 family members both via CHOP and via
TRAF2/ASK1/JNK. Cleaved ATF6 can activate the induction of the pro-apoptotic transcription factor
CHOP and consequently regulate Bcl-2 family members expression. All three branches of UPR can act
concertedly to trigger both mitochondrial and death receptors apoptosis. Moreover, the Ca2+ release
from ER can activate the ER-resident caspase-12/4, which in its active state, can promote the caspase-3
activation leading ultimately to apoptosis. Moreover, in ER stress conditions, oxidative stress induces
the calcium leakage from ER and its subsequent uptake by the mitochondria leading to releasing
cytochrome c from the mitochondrial matrix. Upon ER stress conditions, Ca2+ release from ER and
mitochondrial ROS production alter cellular homeostasis and trigger apoptosis. Abbreviations used
in Figure 1: ASK1: apoptosis signal-regulating kinase; ATF6: activating transcription factor 6; ATF4:
activating transcription factor 4; Bax: (Bcl-2)-associated X protein; Bcl-2: B-cell lynphoma2; BiP: binding
immunoglobulin protein; CHOP: C/EBP homologous protein; eIF2α: Eukaryotic initiation factor 2α;
ER: endoplasmic reticulum; IP3R: inositol 1,4,5,-triphosphate receptor; TRAF2: tumor necrosis factor
receptor-associated factor 2; JNK: JUN N-terminal kinase; ROS: reactive oxygen species.
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In the H1975 human non-small cell lung cancer (NSCLC) cell line, gefitinib-resistant WZ35, an analog
of curcumin, exerts cytotoxic effects by increasing ROS levels and by activating the ER stress pathway [67].
MTH-3, a water soluble curcuminoid derivative, has also been shown to induce intrinsic and extrinsic
apoptosis pathways mediated by ER stress signals in the MDA-MB-231 human breast cancer cell line [68].
The activation of ER stress-related apoptosis in cancer cells can open the way to new therapeutic
options for curcumin and its analogues in cancer therapy. The ER-stress mediated anticancer activity
exerted by curcumin and its analogos is summarized in Table 1.
Table 1. Curcumin and its analogues with ER stress-mediated anticancer activity.
Compound Tumor Type/Cell Line ER Stress Signaling Reference
Curcumin
(Curcuma longa)
Human prostate cancer
PC3
↑ IRE1α; BiP; PDI; calreticulin [59]
Curcumin
(Curcuma longa)
Murine Myeloma
WEHI-3
↑ ATF6; CHOP; IRE1α; caspase-12 [60]
Curcumin + sildenafil
(Curcuma longa)
Human gastric, colon, liver cancer
HC116; HT29; HEPG2
↑ pEIF2α; CHOP [61]
Curcumin + irinotecan
(Curcuma longa)
Human colorectal cancer
HT29; LoVo
↑ CHOP; PDI; BiP [62]
Bisdemethoxycurcumin Human lung cancer
NCI H460
↑ BiP; IRE 1(α and β); CHOP;
ATF6(α and β); caspase-4
[63]
Demetoxycurcumin Human lung cancer
NCI H460
↑ BiP; IRE 1β; CHOP; ATF6(α and
β); caspase-4
[64]
B63
analogue of curcumin
Human colon cancer
SW620
↑ ER stress markers [65]
B19
analogue of curcumin
Human ovarian cancer
A2780; CP70
↑ ROS; p-PERK; pEIF2α; CHOP [66]
WZ35
analogue of curcumin
Human lung cancer
HI975
↑ pEIF2α; ATF4; CHOP [67]
MTH-3
analogue of curcumin
Human breast cancer
MDA-MB-231
↑ CHOP; ERO1; PDI; PERK;
calnexin ↓BiP
[68]
↑-increasing concentration; ↓-decreasing concentration.
4.2. Role of ER Stress in Resveratrol-Induced Apoptosis in Cancer
Resveratrol, a polyphenolic compound belonging to the class of stilbenes, is present in many
plants including grape (mainly skin), blueberries, and peanut, as well as red wine [69]. It has been
shown to arrest the cell cycle and to trigger apoptosis by inhibiting ERK1/2 cascade and modulating
the expression of some proteins involved in DNA synthesis and the cell cycle, such as p53 and
cyclin-dependent kinases [70]. Resveratrol has been found to block cancer growth by targeting different
molecules and pathways involved in cancer development [70]. Recent findings demonstrate its ability
to induce ER stress-related apoptosis in different cancer cell types. In human multiple myeloma cell
lines, resveratrol induces ER stress-related apoptosis by inhibiting the pro-survival XBP1’s function and
by promoting the enrichment of its molecular target sirtuin1 [71]. In the A375SM malignant melanoma
cell line, resveratrol activates apoptosis and cell cycle arrest through enhancing simultaneously ER
stress and ROS production. The A375SM treatment with resveratrol induces the increase of p38, p53,
and Bax expression levels and the decrease of Bcl-2 level. Resveratrol also increases the intracellular
levels of ER stress-related proteins p-eIF2α and CHOP [72]. In the HepG2 human hepatoblastoma
cell line, resveratrol induces ER stress, increasing XBP1 splicing and CHOP expression; moreover,
resveratrol intensifies palmitate-induced cell death of HepG2 cells and increases palmitate-induced ER
stress. Generally, in this cell line, resveratrol promotes an amplification of palmitate toxicity primarily
through ER stress-dependent apoptosis [73]. Moreover, in NCI-H460 human non-small cell lung
cancer cell line, Bai et al. demonstrated a pro-apoptotic activity of resveratrol in miR-200c-positive
cells. To analyze the mechanism of resveratrol in these cells, by using Target Scan, it was possible
to determine the predicted target genes of miR-200c. The authors focused their attention on ER
stress-related proteins, such as RECK, a membrane-bound protein, or ER stress molecules, such as
BiP and CHOP, which all were observed to be increased in miR-200c-transfected cells, leading to
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the conclusion that miR-200c expression sensitizes H460cells to resveratrol, mainly through RECK
expression [74]. In two human nasopharyngeal carcinoma cell lines, NPC-TW076 and NPC-TW039,
resveratrol induced ER stress- and autophagy-related apoptosis as revealed by the marked increase of
IRE1, p-PERK, CHOP, and ATF6. Pretreatment of the cells with specific caspase-12 inhibitors but not
caspase-4 inhibitors, or silencing caspase-4 or -12 by siRNA for 24 h prior to incubation of resveratrol
for 24 h, significantly reduced the activation of caspase-3 and -9 originally induced by resveratrol. In
the same study, resveratrol induced autophagy together with UPR expression and ER dilatation [75].
In human lung adenocarcinoma A549 cells, a resveratrol and arsenic trioxide combination promotes ER
stress- and mitochondrial dysfunction-mediated apoptosis as manifested by the increased expression
of ER stress hallmarks BiP, caspase-12, and CHOP. Moreover, these authors demonstrated that
resveratrol and arsenic trioxide-induced ER stress and mitochondrial dysfunction depended on ROS
production as indicated by the experiments in the presence of N-acetyl-L-cysteine (NAC), a potent ROS
scavenger, that attenuated the expression of ER stress-related markers and the loss of mitochondria
membrane potential [76]. Gwak et al. reported that resveratrol prompts ER stress–related apoptosis
by interfering with protein glycosylation [77]. However, the use of resveratrol has been limited by
its poor solubility and low bioavailability [78]. Drug resistance represents one of the main reasons of
the failure of chemotherapy in different cancers, so the development of novel therapeutic strategies is
highly mandatory. An effective analogue of resveratrol, (Z)3,4,5,4′-trans-tetramethoxystilbene (TMS),
selectively induces cell death of gefitinib-resistant non-small cell lung cancer cells by enhancing the
cytosolic [Ca2+] levels and causing ER stress (as indicated by PERK and eIF2α activation and CHOP
upregulation [79]). A natural demethylated resveratrol analog from blueberries, pterostilbene, exerts
anticancer ER stress-related activity in human esophageal cancer. Indeed, pterostilbene upregulates
BiP, ATF6, p-PERK, p-eIF2α, and CHOP expression, and increases intracellular calcium levels in EC109
esophageal cancer cells. Silencing CHOP by siRNA significantly decreases the pterostilbene-induced
apoptosis. Moreover, in in vivo experiments, this compound was also shown to significantly upregulate
BiP and CHOP expression in EC109 xenografts. These experiments provide evidence of ER-mediated
pro-apoptotic activity of pterostilbene in human esophageal cancer cells [80]. Res-006, a novel
resveratrol derivative, induced cell death in human hepatoblastoma HepG2 cells by triggering ER stress
and mitochondrial dysfunction, providing a rationale for the development of new resveratrol-derived
molecules for cancer treatment targeting both mitochondria and ER stress [81]. The ER stress-mediated
anticancer activity exerted by resveratrol and its analogos is summarized in Table 2.
Table 2. Resveratrol and its analogues with ER stress-mediated anticancer activity.
Compound Tumor Type/Cell Line ER Stress Signaling Reference
Resveratrol Human multiple myeloma
ANBL-6;
↑ IE1α; CHOP; JNK activation
↓XBP1s
[71]
Resveratrol Human melanoma
A375SM
↑ pEIF2α; CHOP [72]
Resveratrol + palmitate Human hepatoblastoma
HepG2
↑ ATF4; CHOP [73]
Resveratrol Human lung cancer
NCI-H460
↑ CHOP; BiP [74]
Resveratrol Human nasopharyngeal cancer
NPC-TW076; NPC-TW039
↑ IRE 1α; CHOP; ATF6α; p-PERK [75]
Resveratrol Human ovarian cancer
Pa-1; MDAH2774; SKOV3
↑ PERK;CHOP; IRE 1α; ATF6α; BiP [77]
Resveratrol + arsenic
trioxide
Human lung cancer
A549
↑ BiP; CHOP; caspase-12 [76]
RES006
Resveratrol analog
Human hepatoblastoma
HepG2
↑ pEIF2α; ATF4; CHOP [81]
TMS
Resveratrol analog
Human lung cancer
A579; H1975
↑ pEIF2α; p-PERK CHOP; IRE1α;
p-JNK
[79]
↑-increasing concentration; ↓-decreasing concentration.
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4.3. Role of ER Stress in Green Tea Polyphenols-Induced Apoptosis in Cancer
Green tea extracts (GTE) possess antitumor activity mainly due to the presence of flavan-3-ols,
specifically epigallocatechin gallate (EGCG). EGCG decreases cell viability and promotes cell death
in many cancer cell lines. While the mechanism of action of GTE has been examined in vitro and
in vivo, the molecular targets of green tea catechins remain to be clarified. Findings from the literature
indicated that GTE flavan-3-ols target ER function [82].
A GTE extract, Polyphenon E®, caused severe and prolonged ER stress in human prostate cancer
cells PC3 by activating the PERK signaling arm, as demonstrated by prolonged activation of p-eIF2α
and ATF4 [83]. A significant activation of XBP1 mRNA splicing has also been observed in these
cells, indicating an involvement of both IRE1α and ATF6 signaling arms of ER stress in the cellular
response to Polyphenon E® [84]. XBP1s is generated by an unconventional splicing reaction upon
disruption of ER homeostasis and is a marker of ER stress activation contributing to upregulation
of CHOP [85]. Polyphenon E® would seem to resensitize cells to chemotherapy compounds, mainly
through the increase of the expression of the pro death protein CHOP. This event seems very important
in prostate cancer cells, which are more susceptible to ER stress, probably because of the remarkable
demand of protein translation and processing, which certainly goes beyond the capacity of cellular
folding proteins. [84]. In MM98 malignant mesothelioma cell line, EGCG induces an acute increase of
BiP, XBP1, CHOP, and ATF4 with simultaneous activation of caspase-3 and -8 [86]. Among a panel
of different ECG and EGCG analogues, JP8 emerged as the most potent autophagy-inducer in B16
melanoma cells. In this cell line, JP8 reduced cell viability and increased apoptosis more effectively
than in normal mouse AML-12 hepatocyte cells. Treatment with ATG5 siRNA diminished JP8-induced
cell death and in these conditions also stress response proteins such as IRE1α, CHOP, p-eIF2α were
downregulated [87].
The ER-stress mediated anticancer activity exerted by green tea polyphenols and its analogos is
summarized in Table 3.
Table 3. Green tea polyphenols and its analogues with ER stress-mediated anticancer activity.
Compound Tumor Type/Cell Line ER Stress Signaling Reference
Polyphenon E® Human prostate cancer
PC3
↑ CHOP [84]
EGCG Human mesothelioma
MM98
↑ BiP; CHOP; ATF4;
XBP1
[86]
JP8
EGCG analog
Melanoma
B16
↑ ATF4; CHOP [87]
EGCG Human bladder carcinoma
T24/83
↑ Binding to BiP [88]
↑-increasing concentration.
4.4. Role of ER stress in Tocotrienols-Induced Apoptosis in Cancer
Vitamin E comprises two groups of compounds: α-, β-, γ-, and δ-tocopherols (TPs), and the
corresponding unsaturated tocotrienols (TTs). α-Tocopheryl succinate, a derivative of α-tocopherol,
induces apoptosis in SGC-7901 human gastric cell line increasing the expression of the main ER
stress-associated molecules, BiP, CHOP, and caspase-4. Moreover, in the presence of antioxidant NAC,
the mRNA and protein expression of BIP and CHOP was inhibited, indicating that in SGC-7901 cells,
α-tocopheryl succinate induced ER stress through ROS production [89]. The other component of
vitamin E is represented by TTs. TTs are present in different natural sources such as red palm oil,
annatto seeds, and rice bran. Recently, TTs (specifically, γ-TT and δ-TT) have sparked interest due
to their health-related activities in chronic pathologies based on their antioxidant, neuroprotective,
cholesterol-lowering, and anti-inflammatory roles. Several in vitro and in vivo studies highlighted
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the antitumor effects of TTs in many types of cancer cells. Especially, TTs were shown to exert
anti-proliferative/pro-apoptotic effects, to affect cancer stem cell subpopulation [90], and to decrease
the metastatic or angiogenic abilities of different cancer cells [91]. In malignant +SA mammary
epithelial cell lines, γ-TT-induced apoptosis is mediated by the PERK/eIF1α/ATF4 ER stress response
pathway and by the increased expression of the pro-apoptotic protein CHOP and TRB3 [92]. Another
study, focusing on the molecular mechanisms of anticancer activity of γ-TT in breast cancer cell lines,
showed that in MDA-MB-231 and MCF-7 cells, γ-TT induced apoptosis, at least in part, mediated by ER
stress. In these cells, ER stress induction of JNK and p38 MAPK followed by up-regulation of DR5 in a
CHOP-dependent manner was demonstrated to be involved in γ-TT-prompted apoptosis [93]. Patacsil
et al. demonstrated that, in the MDA-MB-231 and MCF-7 breast cancer cell lines, γ-TT induced ER
stress-mediated apoptosis as demonstrated by gene expression microarray analysis. Indeed, microarray
analysis highlighted the modulation of genes involved in the ER stress response, such as ATF3, a target
gene for ATF4; the authors demonstrated that ATF3 had a crucial role in γ-TT-induced apoptosis in
MCF-7 cells. Moreover, an up-regulation of the ER stress-related protein markers BiP, ATF4, PERK,
and IRE1α was observed in both MDA-MB-231 and MCF-7 cells treated with γ-TT [94]. In these cell
lines, the cytotoxic activity of γ-TT was associated with the concerted induction of autophagy and
ER stress-mediated apoptosis, since γ-TT also activated LC3-I conjugation to ATG5-ATG12 and the
conversion of LC3-I in to its lipidated and autophagosome-bound form LC3-II [95].
Comitato et al. demonstrated that, in the HeLa human cervical cancer cell line, and in the MCF-7
human breast cancer cell line, γ- and δ-TT induced apoptosis by triggering signals originating from
ER stress. Indeed, after TTs treatment the expression of p-IRE1α, XBP-1, and CHOP was increased. γ-
and δ-TT induced the expression of caspase-12 in HeLa cells treated with δ-TT, and this activation was
associated with caspase-9 cleavage [96].
The role of δ-TT was investigated by Montagnani Marelli et al. in two different human melanoma
cell lines, BLM and A375, using in vitro and in vivo experiments. The authors found that δ-TT exerts a
significant anti-proliferative/pro-apoptotic effect on both cell lines but not on normal melanocytes,
demonstrating that, in both cell lines, δ-TT induced the expression of different ER stress markers such
as BiP PERK, IRE1α, p-EIF2α, ATF4, and CHOP. The cleavage of caspase-4 was also triggered by δ-TT
in both melanoma cell lines. In the presence of ER stress inhibitors the pro-apoptotic activity of δ-TT
was in part counteracted, underlying the fact that the ER stress pathways could represent a relevant
target for melanoma treatment [97]. The ER-stress mediated anticancer activity exerted by tocotrienols
is summarized in Table 4.
Table 4. Tocotrienols with ER stress-mediated anticancer activity.
Compound Tumor Type/Cell Line ER Stress Signaling Reference
α-Tocopheryl succinate Human gastric cancer
SGC-7901
↑ BiP; CHOP; caspase-4; [89]
γ-tocotrienol Malignant +SA mammary
epithelial cell line
↑ p-PERK; p-EIF2α; ATF4;
CHOP
[92]
γ-tocotrienol Human breast cancer
MDA-MB-231
↑ BiP; ATF4; CHOP; XBP1 [93]
γ-tocotrienol Human breast cancer
MCF-7; MDA-MB-231
↑ PERK; p-EIF2α; ATF4; CHOP [94]
γ-tocotrienol Human breast cancer
MCF-7; MDA-MB-231; MCF10A
↑ p-PERK; p-EIF2α; ATF4;
CHOP; TRB3
[95]
γ-tocotrienol
δ-tocotrienol
Human cervical and breast cancer
HeLa; MCF-7
↑ p-IRE1α; XBP1s; CHOP;
caspase-12
[96]
δ-tocotrienol Human melanoma
BLM; A375
↑ BiP; CHOP; PERK; IRE1α;
p-EIF2α; ATF4; CHOP; caspase-4
[97]
↑-increasing concentration.
Int. J. Mol. Sci. 2019, 20, 961 12 of 24
4.5. Role of ER Stress in Garcinia-Induced Apoptosis in Cancer
Mangosteen (Garcinia mangostana L.) is a fruit used as a traditional herbal medicine in Southeast
Asia for the treatment of inflammation, amenorrhea, and abdominal pain [98], which contains various
xanthones including α-mangostin, γ-mangostin, and garcinone E with antitumor effects in different
cancer cell lines [99]. Sato et al. primarily hypothesized that the pro-apoptotic activity of α-mangostin
was related to the ER stress pathway in PC12 cells. As with thapsigargin, α-mangostin induced apoptosis
via sarcoplasmic/endoplasmic Ca2+ ATPase (SERCA) inhibition [100]. In the LNCaP and 22RV1 human
prostate cancer cell lines, a mangosteen fruit extract (MFE) induced an increased expression of ER stress
markers such as PERK, CHOP, IRE1α, BiP, and cleaved caspase-4. At the same time, calnexin, an ER
membrane protein guaranteeing accurate protein folding and quality control, was reduced. On the other
hand, in normal prostate epithelial cells, MFE exerted an opposite effect by reducing PERK expression,
indicating that this extract selectively targets prostate cancer cells. This ER stress induction correlates
with increased apoptotic death [101]. In a subsequent paper, the same authors surprisingly observed
that after CHOP silencing, α-mangostin-treated 22RV1 cells showed significantly increased cleaved
caspase-3 expression. The effect was not observed in LNCaP cells [102]. Another xanthone present in
mangosteen fruit, Garcinone E, was able to reduce the proliferation of ovarian cancer cells by triggering
ER stress and significantly enhancing the protein expression levels of IRE-1α, XBP-1, BiP, CHOP, and
caspase-12. It also exerted anti-migratory and anti-invasion effects, resulting in becoming a potential
future candidate as an anti-ovarian cancer compound [103]. Gartanin, a polyphenolic xantone isolated
from mangosteen fruit, has been shown to exert antitumor activities in different human malignant
cells [104]. Li et al. demonstrated that gartanin activates an apoptotic pathway by modulating the
expression of ER stress chaperons and markers in the 22RV1 and LNCaP human prostate cancer cell
lines. For the first time, these authors provided evidence suggesting that degradation of androgen
receptor (AR) is regulated by the ER stress pathway. CHOP knockdown, indeed, partly reversed
the gartanin-induced reduction in AR protein expression, suggesting a possible interplay between
UPR activation and AR signaling [105]. Garcinol, a polyisoprenylated benzophenone, derived from
Garcinia indica exerts antitumor activity in various cancer cells [106]. In Hep3B cells, garcinol induced
ROS generation and increased the levels of CHOP; these changes resulted in downstream apoptosis
activation with an increase of the Bax/Bcl-2 ratio; a decrease of the mitochondrial membrane potential;
the release of cytochrome c; and the activation of caspase-9, caspase-3, and their target PARP [106].
Gambogic acid (GA) represents the main active compound of Garcinia hanburyi, possessing potent
antitumor activity in a broad range of human cancers [107,108]. GA has been shown to induce apoptosis
through ER stress activation in the HeLa human cervical carcinoma cell line. GA was able to induce
XBP1 splicing and to up-regulate BiP, CHOP, and GADD34 mRNAs. GA induced the ER-related
apoptosis pathway through up-regulation of JNK and down-regulation of ERK in HeLa cells [109]. The
ER-stress mediated anticancer activity exerted by Garcinia derivates is summarized in Table 5.
Table 5. Garcinia derivatives with ER stress-mediated anticancer activity.
Compound Tumor Type /Cell Line ER Stress Signalling Reference
α-Mangosteen Pheochromocytoma
PC12
↓ Ca2+ ATPase activity; ↑ JNK [100]
Mangosteen fruit extract Human prostate cancer
LNCaP; 22RV1
↑ BiP; PERK; IRE1α calnexin
CHOP; caspase-4
[102]
Garcinone-E Human ovarian cancer
HEY; A2780
↑ BiP; IRE1α; XBP1; CHOP;
caspase-12
[103]
Gartanin Human prostate cancer
LNCaP; 22RV1
↑ CHOP [105]
Garcinol Human hepatocellular carcinoma
Hep3B
↑ CHOP [106]
Gambogic acid Human cervical carcinoma
HeLa
↑ BiP; XBP1s; CHOP; GADD34;
JNK
[109]
↑-increasing concentration; ↓-decreasing concentration.
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4.6. Role of ER Stress in Other Natural Compound-Induced Apoptosis in Cancer
Recent papers published in 2018 highlighted the relevance of ER stress in the pro-apoptotic cell
death pathway induced by different plan-derived natural compounds in various human cancers.
In human breast cancer cell lines, MCF-7 and MDA-MB 231, pimpinelol, a linear sequiterpene
lactone from Pimpinella haussknechtii, has been shown to induce apoptosis by increasing protein
aggregation and ER stress, as demonstrated by fluorescence microscopy analysis and by mRNA
expression of ATF4, CHOP, GADD34, and tribbles-related protein 3 (TRIB3) [110].
Pristimerin is a naturally occurring triterpenoid displaying anti-proliferative effects in different
cancer cells [111]. In order to define the mechanisms of action correlated to its antitumor activity,
Cevatemre et al. observed an extensive cytoplasmic vacuolation, ER stress induction, and block of
autophagic flux in MCF-7 breast cancer cells treated with pristimerin, providing new insights into the
mechanisms underlying the activity of pristimerin in breast cancer care [111].
Cnidium officinale Makino (COM) has been used as a traditional medicine for thousands of years in
Korea, China, and Japan for resolving blood stasis, contusions, and infertility. More recently, COM has
been shown to exert antitumor activity in liver, colorectal, and oral cancer. Using Western blot analysis,
it has been demonstrated that ER stress-related proteins, such as p-PERK, p-eIF-2α, and ATF4, were
modified in apoptotic cancer cells treated with COM. This suggests that ER stress-related proteins play
a role in COM-induced cell death. [56].
Although Salvia miltiorrhiza (SM) has been reported to have antitumor effects, such as apoptosis
induction through caspase activation, cell cycle arrest, anti-angiogenic effect, and Bcl-2 family
regulation, the molecular mechanisms of its apoptotic activity need to be demonstrated. Kim et
al., in a recent study, showed the activation of ER stress-related apoptosis via miR-216b by the ethanol
extract of SM. They suggested that SM induces ER stress by producing ROS and that the activated
CHOP expression is followed by an increased miR-216b expression in human multiple myeloma cells
(U266 and U937). In addition, SM reduces c-Jun protein expression, which is a target of miR-216b,
correlated to the induction of the cleavage of caspase-3 and PARP [112].
Protodioscin (PD) represents the principal steroidal saponin in Dioscoreae rhizome exhibiting
antitumor effects in several types of human cancer cells [113]. Lin et al., studying the molecular
mechanisms associated with PD antitumor activity in human cervical cancer cells, have recently
suggested the involvement of mitochondrial dysfunction and BiP/eIF2α/ATF4/CHOP ER stress
branch activation. In their study, the authors demonstrated that the silencing of BiP and CHOP
by siRNA reversed the augmented ER stress-related protein expression by PD and reduced ER
stress-induced apoptosis in cervical cancer cells [114].
Regarding pancreatic cancer cells, by analyzing the anti-cancer effects of Peonia suffruticosa (PS)
aqueous extract, the researchers found an increased activity of caspase-8, -9, and -3, and inhibition
of proteasome activity. They also demonstrated a weak upregulation of death-associated protein
kinase 3, an upstream ER stress-responsive integrator of apoptosis and autophagy, suggesting a partial
implication of ER stress in PS anticancer activity [115].
The mechanism of the anticancer effects of a leaf methanol extract of Clinacanthus nutans, a plant
with cytotoxicity against leukemia cells, was evaluated in the human SUP-T1 lymphoma cell line. This
extract was able to decrease the mitochondria membrane potential, to induce annexin V overexpression,
ROS production, calcium release, and IRE1α and CHOP protein overexpression, indicating that ER
stress is one of the pathways involved in the apoptotic cell death of Clinacanthus nutans [116].
Chrysophanol, an anthraquinone whose antitumor effects have been shown in many in vitro and
in vivo studies [117], has been reported to induce apoptosis in MCF-7 and BT-474 breast cancer cells as
indicated by DNA fragmentation. Moreover, in these cell lines, chrysophanol induced ROS production
and PERK, eIF2α, IRE1α, and CHOP protein expression. Co-treatment of cells with chrysophanol and
NAC reduced the ER stress-related protein expression, indicating that ROS production and ER stress are
important pathways in pro-apoptotic chrysophanol activity in breast cancer cells [118]. Many studies
analyzed the anticancer activity of garlic and garlic-based extracts. In MDA-MB-231 human breast cancer
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cells and in WHCO1 human esophageal-cancer cells, the pro-apoptotic activity of ajoene, an allylsulfur
compound found in garlic, was associated to its ability to induce an ER accumulation of misfolded
proteins and to activate UPR. Using a fluorescently ajoene analogue, the authors demonstrated that this
compound targets and accumulates in ER and increases the levels of BiP [119]. Moreover, the same
authors demonstrated that in WHCO1 cells, the cytotoxic activity of the ajoene analogue BisPMB depends
on increased CHOP expression [120]. Petrovic et al. investigated the molecular mechanism associated
with the anticancer activity of ethanol-based garlic extract (GE) in different mammalian cancer cell lines.
Using a multiplexed inhibitor bead (MIB) assay, significant changes in GE-treated versus control cells
were found for 1000 proteins, and successive KEGG analysis of these proteins indicated that after GE
treatment, proteins involved in the ER response were changed. Therefore, in agreement with other
studies, GE activates apoptosis in many human cancer cells via ER stress and ROS regulation [121].
The antitumor activity of 7-acetylsinumaximol B (7-AB), isolated from soft coral Sinularia sandensis,
was evaluated in the NCI-N87 human gastric cell line. 7-AB-treated cells exhibited increased Bad,
Bim, Bax, cytochrome c, and cleaved caspase-9 and -3 expression levels, suggesting that the apoptotic
intrinsic pathway was activated in the 7-AB-induced cell death. Western blot analysis showed increased
expression of p-PERK, p-eIF2α, ATF4, CHOP, and p-ATF2 proteins in 7-AB-treated cells. These results
indicated that the 7-AB pro-apoptotic activity is partially mediated by the PERK/p-eIF2α/ATF4/
CHOP ER stress pathway [122]. 4-nerolidylcatechol, a compound extracted from Pothomorphe
umbellata L., has been shown to induce apoptosis via ER stress, both in SK-MEL-28 N and in BRAi/MEKi
resistant melanoma cells [123]. Moreover, the role of the monomers PP-22, isolated from Paris polyphilla,
was investigated on apoptosis and autophagy in nasopharyngeal carcinoma cell line. It has been
demonstrated that PP-22 up-regulates PERK, BiP, PDI, ERO1α, IRE, and CHOP proteins, and induces
apoptosis via mitochondrial and p38MAPK pathways. Moreover, PP-22 triggered autophagy by
inhibiting the ERK signaling pathway in CNE-2 cells [124]. A list of the natural compounds discussed
in this section is summarized in Table 6.
Table 6. List of different natural compounds, published in 2018, with ER stress-mediated
anticancer activity.
Compound Tumor Type /Cell Line ER Stress Signaling Reference
Pimpinelol
(Pimpinella haussknechtii)
Human breast cancer
MCF-7
↑ ATF4; CHOP; GADD34; TRIB3 [110]
Pristimerin
(Maytenus sp)
Human breast cancer
MCF-7
↑ ATF4; CHOP; IRE1α; pEIF2α [111]
Cnidium officinale Makino Human myeloid lymphoma
U937; U266
↑ p-PERK; pEIF2α; ATF4; CHOP [56]
Salvia Miltiorrhiza Human myeloid lymphoma
U937; U266
↑ p-PERK; pEIF2α, ATF4; CHOP [112]
Protodioscin
(Dioscoreae rhizome)
Human cervical cancer
HeLa; C33A
↑ BiP; p-PERK; pEIF2α, ATF4;
CHOP; JNK
[114]
Paenia suffruticosa Human pancreatic cancer
PANC1; AsPC1; BxPC3
↑ DAPK3 [115]
Clinacanthus nutans Human lymphoma and leukemia
SUP-T1; MOLT-4
↑ IRE1α; CHOP [116]
Chrysophanol Human breast cancer
MCF-7; BT-474
↑ ROS; p-PERK; pEIF2α; CHOP [118]
Garlic extract Human multiple myeloma and human
prostate cancer
RPMI-8226; DU145
↑ BiP; MAPK kinases; RBX1; SKP1 [121]
Ajoene
(allyl sulfur compound
from garlic)
Human breast cancer and human
esophageal cancer
MDA-MB-231; WHC1O
↑ BiP; CHOP [120]
7-Acetylsinumaximol B
(Sinularia sandensis)
Human gastric cancer
NCI-N87
↑ p-PERK; pEIF2α; ATF4; CHOP;
p-ATF6
[122]
4-nerolidylcatechol
(Pothomorphe umbellata L)
Human melanoma
SK-MEL-28;
BRAi/MEKi SK-MEL-28
↑ p-PERK; IRE1α; BiP; ATF4; CHOP [123]
PP-22
(Paris polyphilla)
Human nasopharyngeal carcinoma
CNE-2
↑ PERK; CHOP; BiP; PDI; ERO-LA;
IRE-LA
[124]
↑-increasing concentration.
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5. Conclusions
Cancer is one of the prevalent causes of death in the world today. In recent decades, although
significant advances have been achieved in cancer therapy, such as chemotherapy, targeted therapy,
radiotherapy, surgery, and immunotherapy, these conventional therapeutic approaches are characterized
by awful side effects and the development of resistance [125–128]. Consequently, one of the
major purposes for cancer care is to discover innovative therapeutic approaches that are able to
selectively destroy malignant cells without damaging normal cells, and to diminish chemotherapy
resistance [129,130]. In cancer cells, different conditions, such as hypoxia and lack of glucose, can
lead to ER perturbation with an impact on protein folding in the ER, resulting in the accumulation of
unfolded proteins, known as ER stress [3,31]. In response to ER stress, cells in the beginning activate an
adaptive signaling pathway, called the unfolded protein response, to overwhelm stress and re-establish
ER homeostasis [3]. On the other hand, unresolved severe ER stress can lead to the activation of both
pathways of apoptosis. Clarifying the mechanisms originated by the different ER stress pathways with the
purpose to endorse cell death or cell survival induction represents a significant issue in this field and will
support the researchers in the development of new effective drugs for innovative anticancer therapeutic
strategies. Natural compounds not only prompt apoptosis but are also able to reduce the resistance to
chemotherapy via modulation of the ER stress pathways. Although numerous studies have demonstrated
that plant-derived natural compounds exert their anticancer activity by inducing a chronic ER stress,
some authors have pointed out that some natural molecules exhibit antitumor activity by inhibiting ER
stress-related proteins to reduce adaptative UPR. About this, it has recently been shown that an ethyl
acetate extract from Scindapsus cf. hederaceus (SH-EAE), by decreasing the expression of PERK and IRE1α,
exerts anti-proliferative and anti-migratory activities in human lung cancer cells; moreover experiments
in zebrafish demonstrated that a decreased expression of PERK and IRE1α in SH-EAE-treated lung cancer
cells is accompanied by the reduction of vessels development, suggesting an antiangiogenic effect [131].
The expression of ER stress sensor BiP may be enhanced in metastatic cells, and BiP could represent
an advantageous therapeutic target [132]. Although knockdown of BiP by siRNA increases cell death
in vitro [133], this may be difficult to reach in vivo and alternative approaches aimed at inhibiting GRP78
may be more effective as therapeutic strategies. In MDA-MB-231 and T-47 human breast cancer cells,
EGCG is able to block the ATPase domain of BiP, suppressing its anti-apoptotic function, and sensitizes
these cells to etoposide-induced caspase-7 activation and apoptosis [134]. The ER stress-mediated
antitumor activity exerted by a great number of natural compounds has been demonstrated in many
in vitro studies, as reported in this review, and the cytotoxic effects of these molecules have also been
confirmed by in vivo studies. Recently, some studies investigated the relationship between antitumor
activity of natural compounds and the ER stress modulation also in in vivo models. Chen et al. found
that isoalantolactone, an active sequiterpene naturally present in many vegetables and medicinal plants,
induces apoptosis in PC3 and DU145 prostate cancer cells via ROS production and ER stress activation.
In vivo, isoalantolactone inhibits DU145 xenograft tumor growth and weight and increases the expression
of CHOP in tumor tissue lysates [135]. Betulinic acid, a triterpenoid isolated from Betula pubescens,
enhances taxol chemosensitivity in breast cancer xenografts; the immunohistochemistry assay revealed
that betulinic acid up-regulates the expression of BiP and CHOP, both alone or combined with taxol,
confirming the results obtained in vitro [136].
As mentioned, natural compounds provide an important role in anticancer therapy [137–141].
Several epidemiologic studies have highlighted how consumption of plant-based foods, rich in
phytochemicals, such as curcumin, resveratrol, and EGCG, are associated with a lower risk of many
chronic diseases, including cancer [141,142]. In this review, we presented different studies that suggest
how natural compounds can constitute an important arsenal of chemical molecules able to modulate
ER stress (both as ER stress inducers and attenuators) to induce cancer cell death. Since the dual
role of UPR in tumor progression is well established, it is crucial to understand how and when its
modulation can change the balance between pro-survival and pro-death pathways; it has been shown
that natural compounds can lead to death both by blocking the adaptive UPR and by promoting
Int. J. Mol. Sci. 2019, 20, 961 16 of 24
sustained ER stress; therefore, since the UPR signaling is a dynamic event, when we examine the
ability of natural compounds to modulate ER stress, it is very important to consider the timing and the
doses of treatment to be sure to obtain the desired cytotoxic effect.
Nevertheless, further studies are required to better define the molecular mechanisms associated
with the anticancer activity of natural compounds in order to convert them to potential effective
anticancer drugs.
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